Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones.
Ndacayisaba LJ, Rappard KE, Shishido SN, Ruiz Velasco C, Matsumoto N, Navarez R, Tang G, Lin P, Setayesh SM, Naghdloo A, Hsu CJ, Maney C, Symer D, Bethel K, Kelly K, Merchant A, Orlowski R, Hicks J, Mason J, Manasanch EE, Kuhn P. Ndacayisaba LJ, et al. Among authors: ruiz velasco c. Curr Oncol. 2022 Apr 21;29(5):2954-2972. doi: 10.3390/curroncol29050242. Curr Oncol. 2022. PMID: 35621632 Free PMC article.
Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer.
Chai S, Matsumoto N, Storgard R, Peng CC, Aparicio A, Ormseth B, Rappard K, Cunningham K, Kolatkar A, Nevarez R, Tu KH, Hsu CJ, Malihi P, Corn P, Zurita A, Hicks J, Kuhn P, Ruiz-Velasco C. Chai S, et al. Among authors: ruiz velasco c. Mol Cancer Res. 2021 Dec;19(12):2036-2045. doi: 10.1158/1541-7786.MCR-21-0383. Epub 2021 Aug 30. Mol Cancer Res. 2021. PMID: 34462330
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
Malihi PD, Graf RP, Rodriguez A, Ramesh N, Lee J, Sutton R, Jiles R, Ruiz Velasco C, Sei E, Kolatkar A, Logothetis C, Navin NE, Corn P, Aparicio AM, Dittamore R, Hicks J, Kuhn P, Zurita AJ. Malihi PD, et al. Among authors: ruiz velasco c. Clin Cancer Res. 2020 Aug 1;26(15):4143-4153. doi: 10.1158/1078-0432.CCR-19-4100. Epub 2020 Apr 27. Clin Cancer Res. 2020. PMID: 32341031 Free PMC article. Clinical Trial.
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption.
Baud'huin M, Ruiz-Velasco C, Jego G, Charrier C, Gasiunas N, Gallagher J, Maillasson M, Naggi A, Padrines M, Redini F, Duplomb L, Heymann D. Baud'huin M, et al. Among authors: ruiz velasco c. Eur J Cell Biol. 2011 Jan;90(1):49-57. doi: 10.1016/j.ejcb.2010.08.001. Epub 2010 Oct 20. Eur J Cell Biol. 2011. PMID: 20970218 Free article.
Osteoprotegerin: multiple partners for multiple functions.
Baud'huin M, Duplomb L, Teletchea S, Lamoureux F, Ruiz-Velasco C, Maillasson M, Redini F, Heymann MF, Heymann D. Baud'huin M, et al. Among authors: ruiz velasco c. Cytokine Growth Factor Rev. 2013 Oct;24(5):401-9. doi: 10.1016/j.cytogfr.2013.06.001. Epub 2013 Jul 1. Cytokine Growth Factor Rev. 2013. PMID: 23827649 Free article. Review.
Key roles of the OPG-RANK-RANKL system in bone oncology.
Baud'huin M, Duplomb L, Ruiz Velasco C, Fortun Y, Heymann D, Padrines M. Baud'huin M, et al. Among authors: ruiz velasco c. Expert Rev Anticancer Ther. 2007 Feb;7(2):221-32. doi: 10.1586/14737140.7.2.221. Expert Rev Anticancer Ther. 2007. PMID: 17288531 Review.
Proteases and bone remodelling.
Georges S, Ruiz Velasco C, Trichet V, Fortun Y, Heymann D, Padrines M. Georges S, et al. Among authors: ruiz velasco c. Cytokine Growth Factor Rev. 2009 Feb;20(1):29-41. doi: 10.1016/j.cytogfr.2008.11.005. Epub 2008 Nov 28. Cytokine Growth Factor Rev. 2009. PMID: 19041277 Review.
18 results